Injectable Product of the Year

JUVÉDERM® VOLUX is part of the JUVÉDERM® VYCROSS collection of hyaluronic acid (HA) facial fillers that are designed and tailored for the most treated areas of the face.(1) The JUVÉDERM® VYCROSS collection has continued to grow in size over the years and Juvéderm® VOLUX is the latest addition to the collection, having been launched at an international level in June 2019. 

The treatment is specially formulated to restore and create volume in the chin and jaw area(2) Juvederm Volux injectable gel is a safe, effective, and durable alternative to surgical treatments for increasing chin projection and jaw volume and results in high patient satisfaction3.It also provides facial definition that can last up to 18-24 months (2)(3) , (individual results may vary)

APTOS Threads from Novus Medical - the distributor already associated with a string of effective treatment options such as Cool Laser and the leading non-surgical anti-snoring treatment, Somnilase - offer an effective alternative to the gold-standard that is surgery and can be used by medical professionals to offer a plethora of non-surgical treatments including non-surgical rhinoplasty, as well as a wide range of anti-ageing treatments such as a lower face-lift, brow lift, neck lift. Due to their immense versatility, APTOS threads can be used on the body to carry out treatments such as non-surgical breast-lifts.

Aliaxin® is designed for the restoration of skin volume, redefining contours and filling wrinkles and skin depressions. The fundamental elements that define the product are tissue integration, the multiple combinations of hyaluronic acid with different molecular weights, high cohesivity and the purity of the hyaluronic acid to maintain each face's expressions.

Manufactured by IBSA  Italia and designed to provide practitioners with versatile, high-quality injectables that work extremely well alone or in combination to suit the needs of virtually every dermalfiller patient.

The Hydrolift® technology behind Aliaxin focuses on the physical parameters of the cross-linking process in order to minimize the use and consequently the residual presence of BDDE in the formulation.

IBSA's own SHYALT® hyaluronic acid is an ultrapure grade ranking as "top high quality" worldwide in terms of purity and safety.

The Patented Formula enables Extra Cellular Matrix regeneration to restore skin elasticity and natural volume. The synergistic action of Hyaluronic Acid with 6 Amino Acids and precisely designed cell nutrients that helps patients discover their natural features and enhance complexion. Sunekos® provide solutions for a number of skin conditions, including, skin-ageing, postacne, scars, dermatitis, hyperpigmentation and melasma.

Teosyal RHA is the first hyaluronic acid dermal filler specifically designed to respect and adapt to facial dynamics, resulting in a hyaluronic acid gel structure and behaviour that is bio-similar to the make-up of our natural hyaluronic acid. 

The range is complete with five products, each product featuring rheological properties that have been tailored and adapted to meet the anatomical requirements of the area in which the product is placed.

Products from the Teosyal RHA range can be used in isolation, or in conjunction with one another where desired to address a variety of patient concerns.

DESIRIAL® PLUS represents a real breakthrough in the Aesthetic industry. Since its CE approval in 2011, DESIRIAL® PLUS not only raises the necessity to inform and educate practitioners about genital aesthetic procedures as part of their training but it also offers a safe alternative for many women. Unspoken about, taboo, gynaecological concerns are unveiled to the public as a result.

DESIRIAL® PLUS is highly popular and demanded across the globe and since 2019 and the opening of a VIVACY subsidriary in London, many UK practitioners have discovered the procedure and started offering it in their clinic.

The strategical interaction between the specific rheology of the product adapted to the histological needs of the tissues, the patented IPN-Like Technology and the addition of mannitol to preserve the HA gel at the moment of injection allow the practitioner to deliver optimal, safe results.

Camille Nadal, UK country Director of VIVACY, states: “Since the creation of DESIRIAL® PLUS, we are absolutely convinced of the added value that this product can offer to the Aesthetic market. It is a fabulous product, delivering great results, and having a positive impact on womanhood. We are immensely proud to be part of these Awards. It is an expression of this industry’s recognition for our work and an inspiration to keep going.”